Proteomic approach toward personalized sarcoma treatment: lessons from prognostic biomarker discovery in gastrointestinal stromal tumor (Q38071053)

28 August 2017

1 reference

title

Proteomic approach toward personalized sarcoma treatment: lessons from prognostic biomarker discovery in gastrointestinal stromal tumor (English)

1 reference

28 August 2017

0 references

Tadashi Kondo

1

1 reference

28 August 2017

Yoshiyuki Suehara

2

1 reference

28 August 2017

Kazutaka Kikuta

3

1 reference

28 August 2017

Daisuke Kubota

4

1 reference

28 August 2017

Takashi Tajima

5

1 reference

28 August 2017

Kenta Mukaihara

6

1 reference

28 August 2017

Hiroshi Ichikawa

7

1 reference

28 August 2017

Akira Kawai

8

1 reference

28 August 2017

publication date

1 January 2013

1 reference

Proteomics - Clinical Applications

28 August 2017

published in

1 reference

28 August 2017

volume

7

1 reference

28 August 2017

issue

1-2

1 reference

28 August 2017

page(s)

70-78

1 reference

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

PDGFRA activating mutations in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

The molecular biology of soft-tissue sarcomas and current trends in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Recent advances in the molecular pathology of soft tissue sarcoma: implications for diagnosis, patient prognosis, and molecular target therapy in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Gastrointestinal stromal tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

High incidence of microscopic gastrointestinal stromal tumors in the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Application of proteomics to soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Isolation from cochlea of a novel human intronless gene with predominant fetal expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

The parapineal mediates left-right asymmetry in the zebrafish diencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Temporally regulated asymmetric neurogenesis causes left-right difference in the zebrafish habenular structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Genome-wide association study of bipolar I disorder in the Han Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Heterogenous GABA(B) receptor-mediated pathways are involved in the local GABAergic system of the rat trigeminal ganglion: possible involvement of KCTD proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Resequencing of the auxiliary GABA(B) receptor subunit gene KCTD12 in chronic tinnitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Intracellular characterization of DDX39, a novel growth-associated RNA helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Application of 2-D DIGE to formalin-fixed, paraffin-embedded tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Proteomics out of the archive: Two-dimensional electrophoresis and mass spectrometry using HOPE-fixed, paraffin-embedded tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Upregulation of miR-196a and HOTAIR Drive Malignant Character in Gastrointestinal Stromal Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Microarray analysis identifies versican and CD9 as potent prognostic markers in gastric gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Osteopontin expression is an independent adverse prognostic factor in resectable gastrointestinal stromal tumor and its interaction with CD44 promotes tumor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Clinical implication and mitotic effect of CD44 cleavage in relation to osteopontin/CD44 interaction and dysregulated cell cycle protein in gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Distinct gene expression-defined classes of gastrointestinal stromal tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Midkine as a prognostic marker for gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

CD44 loss in gastric stromal tumors as a prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Prognostic value of nm23 in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

Elevated (> or = 10%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201200085

21 January 2018

Identifiers

DOI

10.1002/PRCA.201200085

1 reference

28 August 2017

1 reference